Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
5.89
Dollar change
-0.13
Percentage change
-2.16
%
IndexRUT P/E- EPS (ttm)-0.27 Insider Own6.72% Shs Outstand34.25M Perf Week-0.67%
Market Cap210.33M Forward P/E9.90 EPS next Y0.59 Insider Trans0.00% Shs Float33.31M Perf Month-5.15%
Income3.32M PEG- EPS next Q0.05 Inst Own49.73% Short Float2.64% Perf Quarter30.02%
Sales185.36M P/S1.13 EPS this Y198.08% Inst Trans6.62% Short Ratio7.46 Perf Half Y13.93%
Book/sh-0.86 P/B- EPS next Y53.55% ROA2.48% Short Interest0.88M Perf Year-2.16%
Cash/sh2.49 P/C2.36 EPS next 5Y- ROE- 52W Range3.65 - 8.22 Perf YTD19.23%
Dividend Est.- P/FCF7.93 EPS past 5Y-19.96% ROI4.20% 52W High-28.35% Beta0.85
Dividend TTM- Quick Ratio4.56 Sales past 5Y14.07% Gross Margin67.16% 52W Low61.20% ATR (14)0.36
Dividend Ex-Date- Current Ratio5.51 EPS Y/Y TTM-220.48% Oper. Margin17.92% RSI (14)50.78 Volatility4.33% 5.84%
Employees194 Debt/Eq- Sales Y/Y TTM12.37% Profit Margin1.79% Recom1.00 Target Price8.65
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q342.39% Payout0.00% Rel Volume0.61 Prev Close6.02
Sales Surprise-0.24% EPS Surprise118.18% Sales Q/Q2.74% EarningsMar 12 AMC Avg Volume117.79K Price5.89
SMA20-3.03% SMA507.23% SMA2009.01% Trades Volume71,735 Change-2.16%
Date Action Analyst Rating Change Price Target Change
Feb-20-24Initiated B. Riley Securities Buy $9
Feb-01-24Initiated Jefferies Buy
Jun-24-22Initiated Cowen Outperform $11
Jun-23-22Initiated ROTH Capital Buy $9
Mar-13-24 08:37AM
Mar-12-24 06:11PM
04:05PM
Mar-05-24 10:00AM
Feb-27-24 04:05PM
04:05PM Loading…
Feb-20-24 04:05PM
Jan-25-24 04:05PM
Jan-17-24 04:05PM
04:05PM
Jan-11-24 04:05PM
Nov-07-23 08:25PM
04:45PM
Oct-24-23 08:30AM
Aug-10-23 06:40PM
04:30PM
08:30AM Loading…
Jul-27-23 08:30AM
Jul-13-23 09:29AM
Jun-22-23 07:00AM
Jun-08-23 06:05PM
Jun-05-23 07:48AM
May-31-23 08:30AM
May-30-23 08:30AM
May-09-23 05:21PM
05:21PM
Apr-26-23 08:30AM
Apr-10-23 08:30AM
Mar-31-23 09:55AM
Mar-28-23 04:15PM
Mar-27-23 09:00AM
Mar-02-23 08:00AM
04:15PM Loading…
Feb-09-23 04:15PM
Jan-09-23 05:30PM
Jan-05-23 06:00AM
Nov-10-22 08:30AM
Nov-08-22 04:15PM
Nov-07-22 09:15AM
Oct-31-22 08:30AM
Oct-10-22 07:45AM
Sep-07-22 08:30AM
08:30AM
Aug-25-22 04:05PM
Aug-24-22 08:30AM
Aug-15-22 04:56PM
Aug-09-22 04:15PM
Jul-20-22 11:00AM
Jul-18-22 10:24AM
Jun-16-22 08:30AM
Jun-06-22 04:05PM
08:16AM
Jun-03-22 08:59AM
May-26-22 04:05PM
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conlon Mary ElizabethGeneral CounselJul 05 '23Sale6.506,24040,573140,393Jul 06 12:12 PM